27th Sep 2016 06:59
LONDON (Alliance News) - Mid-cap drugmaker Indivior PLC on Tuesday said 35 US states and the District of Colombia now have filed a civil complaint alleging violations of state and federal antitrust and consumer protection laws.
Indivior shares had fallen on Friday after the company had highlighted the plans by the states to file the complaint.
Indivior said the complaint alleges that the company switched its Suboxone Film opioid addiction treatment from a tablet to a film in order to prevent or delay the introduction of generic alternatives.
"The company continues to take these allegations seriously, intends to defend this and other related actions, and will continue to cooperate with the relevant US government agencies in their investigations of the company," Indivior said.
Indivior added it is now assessing this complaint, in addition to investigations into the issue being conducted by the US Federal Trade Commission and the Department of Justice, to determine the implications for any provision it may have to take on its balance sheet related to the litigation.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Indivior